QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
In safety pharmacology studies, the effects on the QT interval of electrocardiograms are routinely assessed using a telemetry system in cynomolgus monkeys. However, there is a lack of integrated databases concerning in vivo QT assays in conscious monkeys. As part of QT Interval Prolongation: Project for Database Construction (QT PRODACT), the present study examined 10 positive compounds with the potential to prolong the QT interval and 6 negative compounds considered to have no such effect on humans. The experiments were conducted at 7 facilities in accordance with a standard protocol established by QT PRODACT. The vehicle or 3 doses of each test compound were administered orally to male cynomolgus monkeys (n=3-4), and telemetry signals were recorded for 24 h. None of the negative compounds prolonged the corrected QT using Bazett's formula (QTcB) interval. On the other hand, almost all of the positive compounds prolonged the QTcB interval, but haloperidol, terfenadine, and thioridazine did not. The failure to detect the QTcB interval prolongation appeared to be attributable for the differences in metabolism between species and/or disagreement with Bazett's formula for tachycardia. In the cynomolgus monkeys, astemizole induced Torsade de Pointes and cisapride caused tachyarrhythmia at lower plasma concentrations than those observed in humans and dogs. These results suggest that in vivo QT assays in conscious monkeys represent a useful model for assessing the risks of drug-induced QT interval prolongation.
Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Tokyo, Japan. k-andou@ankaken.co.jp
Kentaro
K
Ando
Toshiyasu
T
Hombo
Akihiro
A
Kanno
Hironobu
H
Ikeda
Masakazu
M
Imaizumi
Noritsugu
N
Shimizu
Kengo
K
Sakamoto
Shin-ichi
S
Kitani
Yoshinori
Y
Yamamoto
Shingo
S
Hizume
Keiko
K
Nakai
Tetsuya
T
Kitayama
Keiji
K
Yamamoto
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002940:Circadian Rhythm; D016208:Databases, Factual; D064420:Drug-Related Side Effects and Adverse Reactions; D004562:Electrocardiography; D008133:Long QT Syndrome / Q000139:chemically induced*; D008252:Macaca fascicularis; D008297:Male; D023421:Models, Animal; D004364:Pharmaceutical Preparations / Q000097:blood; D010599:Pharmacokinetics; D013686:Telemetry
D004364:Pharmaceutical Preparations